Basic sleep and circadian science as building blocks for behavioral interventions: A translational approach for mood disorders.

Asarnow, Lauren D.; Soehner, Adriane M.; Harvey, Allison G.

doi:10.1037/a0035892

Cited by 13 publications

(10 citation statements)

References 128 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Nonetheless, there is robust evidence for causal (often bidirectional) links between sleep and negative mood, including major depression (Harvey, 2011; Malhi and Kuiper, 2013). Consequently, a comprehensive approach to lifestyle in the maintenance phase of major depression should include assessment and where appropriate behavioural intervention for improving sleep (Asarnow et al, 2014). As with diet and exercise prescription, clinicians may not require specialised skills in behavioural sleep interventions.…”

Section: Clinical Management Of Major Depressive Disordermentioning

confidence: 99%

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

Malhi

Bassett

Boyce

et al. 2015

Aust N Z J Psychiatry

672

681

View full text Add to dashboard Cite

Professor Marie-Paule Austin, Professor Michael Berk, Dr Yulisha Byrow, Professor Helen Christensen, Dr Nick De Felice, A/Professor Seetal Dodd, A/Professor Megan Galbally, Dr Josh Geffen, Professor Philip Hazell, A/Professor David Horgan, A/Professor Felice Jacka, Professor Gordon Johnson, Professor Anthony Jorm, Dr Jon-Paul Khoo, Professor Jayashri Kulkarni, Dr Cameron Lacey, Dr Noeline Latt, Professor Florence Levy, A/Professor Andrew Lewis, Professor Colleen Loo, Dr Thomas Mayze, Dr Linton Meagher, Professor Philip Mitchell, Professor Daniel O'Connor, Dr Nick O'Connor, Dr Tim Outhred, Dr Mark Rowe, Dr Narelle Shadbolt, Dr Martien Snellen, Professor John Tiller, Dr Bill Watkins, Dr Raymond Wu.

show abstract

Section: Clinical Management Of Major Depressive Disordermentioning

confidence: 99%

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

Malhi

Bassett

Boyce

et al. 2015

Aust N Z J Psychiatry

672

681

View full text Add to dashboard Cite

show abstract

“…Although interventions able to resynchronize the human circadian system (i.e., SD, light therapy, etc.) have shown some potential in the treatment of depression , there are no data unquestionably supporting the antidepressant efficacy of melatonin and melatonin receptor agonists , with the exception of agomelatine ‐ a MT1/MT2 agonist and 5‐HT 2C antagonist with antidepressant and anxiolytic potency . On the other hand, there is some evidence for (mostly acute) anxiolytic effects of melatonin and melatonin receptor agonists .…”

Section: Melatonergic Effects On Ptsd‐specific Pathophysiological Stamentioning

confidence: 99%

Potential pleiotropic beneficial effects of adjuvant melatonergic treatment in posttraumatic stress disorder

Agorastos

Linthorst

2016

Journal of Pineal Research

View full text Add to dashboard Cite

Loss of circadian rhythmicity fundamentally affects the neuroendocrine, immune, and autonomic system, similar to chronic stress and may play a central role in the development of stress-related disorders. Recent articles have focused on the role of sleep and circadian disruption in the pathophysiology of posttraumatic stress disorder (PTSD), suggesting that chronodisruption plays a causal role in PTSD development. Direct and indirect human and animal PTSD research suggests circadian system-linked neuroendocrine, immune, metabolic and autonomic dysregulation, linking circadian misalignment to PTSD pathophysiology. Recent experimental findings also support a specific role of the fundamental synchronizing pineal hormone melatonin in mechanisms of sleep, cognition and memory, metabolism, pain, neuroimmunomodulation, stress endocrinology and physiology, circadian gene expression, oxidative stress and epigenetics, all processes affected in PTSD. In the current paper, we review available literature underpinning a potentially beneficiary role of an add-on melatonergic treatment in PTSD pathophysiology and PTSD-related symptoms. The literature is presented as a narrative review, providing an overview on the most important and clinically relevant publications. We conclude that adjuvant melatonergic treatment could provide a potentially promising treatment strategy in the management of PTSD and especially PTSD-related syndromes and comorbidities. Rigorous preclinical and clinical studies are needed to validate this hypothesis.

show abstract

“…It is also essential to educate the individual about healthy lifestyle habits, such as regular exercise, balanced diet and good sleep hygiene — all of which are protective against the development of depression and are effective treatment strategies 15 . ‐ 19 In addition, any alcohol or drug use should be appropriately managed either before or alongside commencing treatment for depression.…”

Section: Recommendationsmentioning

confidence: 99%

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary

Malhi

Outhred

Hamilton

et al. 2018

Medical Journal of Australia

View full text Add to dashboard Cite

In December 2015, the Royal Australian and New Zealand College of Psychiatrists published a comprehensive set of mood disorder clinical practice guidelines for psychiatrists, psychologists and mental health professionals. This guideline summary, directed broadly at primary care physicians, is an abridged version that focuses on major depression. It emphasises the importance of shared decision making, tailoring personalised care to the individual, and delivering care in the context of a therapeutic relationship. In practice, the management of depression is determined by a multitude of factors, including illness severity and putative aetiology, with the principal objectives of regaining premorbid functioning and improving resilience against recurrence of future episodes. Main recommendations: The guidelines emphasise a biopsychosocial lifestyle approach and provide the following specific clinical recommendations: Alongside or before prescribing any form of treatment, consideration should be given to the implementation of strategies to manage stress, ensure appropriate sleep hygiene and enable uptake of healthy lifestyle changes. For mild to moderate depression, psychological management alone is an appropriate first line treatment, especially early in the course of illness. For moderate to severe depression, pharmacological management is usually necessary and is recommended first line, ideally in conjunction with psychosocial interventions. Changes in management as a result of the guidelines: The management of depression is anchored within a therapeutic relationship that attends to biopsychosocial lifestyle aspects and psychiatric diagnosis. The guidelines promote a broader approach to the formulation and management of depression, with treatments tailored to depressive subtypes and administered with clear steps in mind. Lifestyle and psychological therapies are favoured for less severe presentations, and concurrent antidepressant prescription is reserved for more severe and otherwise treatment-refractory cases.

show abstract

Basic sleep and circadian science as building blocks for behavioral interventions: A translational approach for mood disorders.

Cited by 13 publications

References 128 publications

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

Potential pleiotropic beneficial effects of adjuvant melatonergic treatment in posttraumatic stress disorder

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary

Contact Info

Product

Resources

About